Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,212 $ 24,494
Short-term investments   6,621
Accounts receivable, net 3,723 9,583
Inventories, net 49,953 60,816
Contract assets 500 7,510
Prepaid expenses and other current assets 2,336 4,000
Total current assets 57,724 113,024
Property and equipment, net 14,270 16,326
Equipment on lease, net 3,673 6,667
Other assets 13,513 17,782
Total assets 89,180 153,799
Current liabilities:    
Accounts payable 18,538 15,854
Accrued expenses and other current liabilities 3,511 6,491
Debt – current portion 5,666 21,191
Contract liabilities 10,285 5,135
Total current liabilities 38,000 48,671
Long-term debt – less current portion 0 11,941
Contingent earnout liabilities (Note 10) 11 1,456
Warrant liabilities (Note 10) 2,167 11,835
Other noncurrent liabilities 9,338 11,556
Total liabilities 49,516 85,459
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at December 31, 2024 and 2023, respectively, 194,909,430 and 7,383,390 shares issued and outstanding as of December 31, 2024 and 2023, respectively 4 2
Additional paid-in capital 469,994 425,471
Accumulated other comprehensive loss   (96)
Accumulated deficit (430,334) (357,037)
Total stockholders’ equity 39,664 68,340
Total liabilities and stockholders’ equity $ 89,180 $ 153,799